AstraZeneca COVID-19 Shot Candidate Shows Promise Among Elderly In Trials
AstraZeneca Plc and Oxford University has developed a potential COVID-19 vaccine that produced a strong immune response in older adults, hoping that it may protect some of those most vulnerable…
Share